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Data summary. All newly determined P. aeruginosa genome sequences are deposited at the 28 
NCBI (BioProject PRJEB8749) with the sequence for strain RW109 (the largest industrial strain 29 
in the dataset) available as GCA_900243355.1 (draft) and GCF_900243355.1 (complete). 30 
Additional draft P. aeruginosa genomes are  deposited as GCA_001374635.1, 31 
GCA_001373635.1, GCA_001373875.1, GCA_001374955.1, GCA_001374115.1, 32 
GCA_001374355.1, GCA_001374455.1, GCA_001374655.1, GCA_001373655.1, 33 
GCA_001373895.1, GCA_001375215.1, GCA_001374135.1, GCA_001374375.1, 34 
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GCA_001373595.1, GCA_001374675.1, GCA_001374995.1, GCA_001375235.1, 35 
GCA_001374155.1, GCA_001374395.1, GCA_001374975.1, GCA_001374435.1, 36 
GCA_001373675.1, GCA_001373915.1 and GCA_000568855.1 (full strain information is 37 
available in Supplementary Table 1) 38 
ABSTRACT 39 
Pseudomonas aeruginosa is a highly versatile, antibiotic resistant Gram-negative 40 
bacterium known for causing opportunistic infections and contamination of industrial 41 
products. Despite extensive genomic analysis of clinical P. aeruginosa strains, no 42 
genomes exist for preservative tolerant industrial strains. A unique collection of 69 43 
industrial isolates was assembled and compared to clinical and environmental strains; 16 44 
genetically distinct industrial strains were subjected to array tube genotyping, multilocus 45 
sequence typing and whole genome sequencing. Industrial strains possessed high 46 
preservative tolerance, were dispersed widely across P. aeruginosa as a species, but 47 
recurrence of strains from the same lineage within specific industrial products and 48 
locations was identified. The industrial P. aeruginosa genomes (mean = 7.0 Mb) were 49 
significantly larger than previously sequenced environmental (mean = 6.5 Mb; n = 19) and 50 
clinical (mean = 6.6 Mb; n = 66) strains. Complete sequencing of P. aeruginosa industrial 51 
strain RW109 which encoded the largest genome (7.75 Mb) revealed a multi-replicon 52 
structure including a megaplasmid (555,265 bp) and large plasmid (151,612 bp). The 53 
RW109 megaplasmid represented an emerging plasmid family conserved in 7 industrial 54 
and 2 clinical P. aeruginosa strains, and associated with extreme stress resilient 55 
phenotypes including antimicrobial resistance and solvent tolerance. Here we show that 56 
by defining the detailed phylogenomics of P. aeruginosa industrial strains, they uniquely 57 
possess multi-replicon, megaplasmid bearing genomes and significantly greater genomic 58 
content worthy of further study. 59 
  60 
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Impact Statement  61 
Multiple industrial products are prone to microbial contamination because they are made in a 62 
non-sterile way and rely on chemical preservatives to prevent spoilage. However, occasional 63 
microbial contamination can result in costly recalls and may pose health risks to consumers. We 64 
studied a unique collection of Pseudomonas aeruginosa bacteria recovered from industrial 65 
products. P. aeruginosa can cause infection in vulnerable people and is recognised as an 66 
antimicrobial resistance threat, but little is known about industrial strains. We DNA sequenced 67 
the industrial strains and compared their genomes to clinical and environmental isolates. 68 
Industrial P. aeruginosa strains had high preservative tolerance and we found certain strain 69 
types re-occurring in the same product type or manufacturing location. Although the industrial 70 
strains were genetically diverse in relation to the P. aeruginosa population, we uniquely 71 
identified that they often carried the same megaplasmid. Megaplasmids are large segments of 72 
DNA that can move between bacteria and carry new functions such as antimicrobial resistance. 73 
The megaplasmid plus other novel genes gave the industrial P. aeruginosa strains very large 74 
genomes. What this extra capacity of 500+ genes brings to industrial P. aeruginosa in relation to 75 
its ability to overcome preservation represents a new challenge in microbiology.  76 
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INTRODUCTION 77 
P. aeruginosa is a widespread human opportunistic pathogen and has been highlighted as a key 78 
global threat in relation to antimicrobial resistant as one of the ESKAPE bacterial infections [1]. P. 79 
aeruginosa is also responsible for chronic lung infections in people with cystic fibrosis (CF) [2], 80 
and understanding the pathogenesis, epidemiology, treatment and antibiotic resistance of clinical 81 
strains have been major foci for research on the bacterium. However, P. aeruginosa is ubiquitous 82 
in the environment and can be isolated from diverse habitats including soil, water and plants [3]. 83 
One significant but largely overlooked aspect of P. aeruginosa’s biology is its ability to survive in 84 
xenobiotic environments such as industry, where it can contaminate raw materials, 85 
pharmaceutical and cosmetic products [4], and even fuels [5]. 86 
Within the home and personal care industry, microbial contamination is a major cause of product 87 
recalls and may represent a threat to consumer health [6]. P. aeruginosa has previously been 88 
linked with infections involving contaminated hand lotion [7], mouthwash [8], and make-up 89 
products [9]. Industrial manufacturers work to a number of guidelines and International 90 
Organisation for Standardisation (ISO) recommendations to prevent contaminated products from 91 
reaching the market place. Preservatives such as parabens, isothiazolinones, formaldehyde 92 
releasers, alcohols and organic acids are widely used to maintain product stability and prevent 93 
microbial proliferation [10]. When preservation barriers fail, global recall databases show that P. 94 
aeruginosa is a major cause of contamination, with for example >33% of cosmetic product 95 
incidents involving the bacterium [11].  96 
Despite the global reach and billion dollar value of the home and personal care industry, the study 97 
of P. aeruginosa strains that contaminate industrial products has been limited. What is clear is 98 
that these P. aeruginosa strains have the ability to overcome the harsh antimicrobial rich 99 
environments found in industry and survive to cause product recalls [4]. Understanding the biology 100 
of these microorganisms is therefore important to protect consumers, prevent costly product 101 
contamination incidents, improve preservation strategies and assess if they are a reservoir for 102 
antimicrobial resistance. Industrial microbiology also represents a relatively unstudied area in 103 
terms of the application of genomics despite microbial contamination impacting multiple global 104 
manufacturing processes. Herein, we have assembled a unique collection of P. aeruginosa 105 
industrial isolates, contextualised their genotypic and phenotypic characteristics against clinical 106 
and environmental strains, and revealed unique insights into their antimicrobial resistance, 107 
genome content and organisation. 108 
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METHODS 109 
Bacterial collection and phenotypic analysis. P. aeruginosa was recovered from 24 110 
contaminated industrial products by serial dilution and growth on selective and non-selective 111 
agars as described [12].  The 69 industrial isolates were combined with a wider collection of 21 112 
strains from the International P. aeruginosa reference panel [13] (IPARP) and additional reference 113 
strains (Table S1). P. aeruginosa isolates were stored deep frozen, revived and routinely grown 114 
on tryptic soya agar (TSA) or in tryptic soya broth (TSB) (Oxoid Ltd, Basingstoke, UK) as 115 
described [14]. For wider analyses, strain information from multiple databases was analysed for: 116 
genome comparison, the Pseudomonas genome database [15] and Genbank; RAPD genotyping 117 
[16];  AT-typing and eBURST analysis [17];  MLST, rMLST and whole genome MLST (Bacterial 118 
Isolate Genome Sequence Database [BIGSdb] and PubMLST) [18]. Details of all 103 strains 119 
examined and which analysis was performed on each are given in Table S1.  120 
Growth curve analysis and swimming, swarming and twitching motility assays were performed as 121 
described previously [14]. Preservative susceptibility testing of P. aeruginosa was carried out 122 
using a microbroth dilution assay essentially as described [19] and the Minimal Inhibitory 123 
Concentration (MIC) for 6 widely used industrial agents determined: Chloromethylisothiazolinone 124 
(CITMIT; Kathon CG, Dow Europe GmbH, Switzerland); Methylisothiazolinone (MIT; Neolone 125 
M10, Dow Europe GmbH); Benzisothiazolinone (BIT; Koralone B-120, Dow Europe GmbH); 126 
Phenoxyethanol (PHE; Clariant Produkte GmbH, Germany); Chlorhexidine (CHX; chlorhexidine 127 
digluconate; Sigma-Aldrich Co. Ltd., UK); and Benzoic acid (BA; Sigma-Aldrich Co. Ltd.) (see 128 
Supplementary Methods for full details).  129 
A biofilm formation assay was adapted from a previously published protocol [20]. Suspensions of 130 
105 cfu/ml of each strain were prepared in TSB and 100 μl inoculated into clear 96-well plates, 6 131 
wells per strain (avoiding edge wells). After incubation at 37°C for 32 hours, growth was discarded 132 
and the wells washed three times with sterile H2O before staining with 200 µl 0.1% (w/v) crystal 133 
violet solution. Wells were then washed with sterile H2O until the washes were clear and left to 134 
air-dry overnight. The crystal violet in each well was solubilised with 200 µl 70% ethanol and the 135 
absorbance measured at 570 nm. Three biological replicates were performed for each strain. 136 
 137 
RAPD and AT-genotyping of P. aeruginosa. RAPD-PCR typing was performed as described 138 
previously using primer 272 [5]. RAPD-PCR products were separated using an Agilent 2100 139 
Bioanalyzer and DNA 7500 chips according to the manufacturer’s instructions. Cluster analysis 140 
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of the RAPD-PCR profiles was performed using the Gel Compar package within Bionumerics 6.6 141 
software (Applied Maths). A Pearson correlation similarity coefficient with a UPGMA dendrogram 142 
type was used to determine similarity between profiles; strains sharing ≥80% profile similarity 143 
were considered the same RAPD type [5]. 144 
The Clondiag Array Tube (AT) P. aeruginosa genotyping kit (Alere Technologies Gmbh, Jena, 145 
Germany) was used to genotype selected industrial/reference strains (Table S2) as described 146 
previously [21]. The relatedness of the P. aeruginosa strains was determined by comparison of 147 
the hexadecimal codes obtained for each strain to a 1464-strong database of clinical and 148 
environmental strains [those with complete profiles in the database of [17] using the eBURST 149 
algorithm (http://eburst.mlst.net) [22]. 150 
Draft genome sequencing of P. aeruginosa. DNA was extracted from 19 P. aeruginosa strains 151 
(16 industrial  strains and 3 reference strains used in industrial testing;  Table S3) as described 152 
[23] (see Supplementary Methods) and subjected to genome sequencing. Five additional P. 153 
aeruginosa strains (4 clinical, 1 environmental and 1 of unknown source) were also subjected to 154 
sequencing (Table S3). Genomic library preparation and sequencing was performed at the Oxford 155 
Genomics Centre of the Welcome Trust Centre for Human Genetics. DNA sequencing was 156 
achieved using 100-bp paired-end Illumina HiSeq2000 technology. De novo assembly of 157 
genomes from the paired-end sequence data was performed using SPAdes Genome Assembler 158 
v3.5.0. Assembled genomic data in contigs were deposited in the PubMLST database, supported 159 
by the BIGSdb software [18]. MLST sequencing types (ST) were determined using the PubMLST 160 
database. The genomes were deposited in BIGSdb, assigned accession numbers (Table S1; 161 
BioProject PRJEB8749) and scanned for the 7 P. aeruginosa MLST loci [24] to identify allele 162 
types and STs. The details of other strains in the database sharing the same ST were recorded 163 
to determine origins of STs. 164 
Complete sequencing of P. aeruginosa RW109. Single Molecule Real-Time (SMRT) 165 
sequencing (Pacific Biosciences, PacBio, California, USA) of P. aeruginosa RW109 (ENA 166 
accession GCA_900243355.1) was performed by the Centre for Genomic Research, University 167 
of Liverpool, essentially as described [23]. All bioinformatic analysis of the data was carried out 168 
using a virtual machine hosted by the Cloud Infrastructure for Microbial Bioinformatics (CLIMB) 169 
consortium [25] and full details of the sequencing and assembly processes are given in the 170 
Supplementary Methods. The assembled genome was analysed as follows: annotation was 171 
carried out using Prokka [26], Cluster of Orthologous Group (COG) determined as described [27], 172 
 7 
 
Kyoto Encyclopedia of Genes and Genomes (KEGG) function assigned [28] and examined for 173 
enrichment in preservative tolerant strains,  phages located using the PHAge Search Tool 174 
Enhanced Release (PHASTER) (v1.0) [29] and genomic islands  predicted using Islandviewer 175 
(v4.0)  [30] (see Supplementary Methods).  176 
Comparative genome analysis of RW109 was performed against the complete genome sequence 177 
FASTA files of the clinical P. aeruginosa reference strains UCBPP-PA14 (PA14) (Accession: 178 
CP000438) and PAO1 (Accession: AE004091) (Winsor et al., 2016). Each genome was 179 
annotated using Prokka and run through the Quality Assessment Tool for Genome Assemblies 180 
(QUAST), (v4.5.5) [31], prior to comparison against the RW109 strain. The Circular Genome 181 
Viewer (CGView) application and CGView source code [32] were used via the command line to 182 
convert Prokka generated GeneBank files into CGView XML files for generation of a RW109 183 
genome circular map. The CDS were coloured according to the assigned COG categories, and 184 
the RW109 GIs and prophage sequences were also illustrated on the map. 185 
P. aeruginosa pan genome analysis. The Roary pipeline (v3.7.0) [33] was used for pan-genome 186 
comparisons of the RW109 strain with genome sequences of P. aeruginosa strains isolated from 187 
clinical, environmental and industrial sources. In total, a reference set of 103 genomes were 188 
analysed (Table S1). All the FASTA sequences of the strains were re-annotated using Prokka 189 
[26] and the resulting GFF files analysed with Roary [33]. The –e parameter was applied to create 190 
a multi-FASTA codon aware alignment of all the core genes using PRANK [34]. The core-gene 191 
multi-FASTA alignment file (MAFFT) was used to build a phylogenetic maximum-likelihood tree 192 
based on 1,000 bootstrap resampling replicates with FastTree (v2.1.8) [35]. The Generalized 193 
Time-Reversible (GTR) model with default settings was applied. The tree was visualised with 194 
FigTree (v1.4.3, http://tree.bio.ed.ac.uk/software/figtree/). From the Roary pan-genome analysis, 195 
the gene presence and absence output was used to determine the genes specific to the P. 196 
aeruginosa RW109 strain which were not identified in the 102 P. aeruginosa genome sequences. 197 
Prediction of antimicrobial resistance genes. The FASTA sequences of the 103 P. aeruginosa 198 
genomes were analysed using the ABRicate tool (v0.5-dev, 199 
https://github.com/tseemann/abricate.git) and antimicrobial resistance genes predicted by 200 
Comprehensive Antibiotic Resistance Database (CARD) [36]. A ≥80% cut off was used for both 201 
coverage and identity ABRicate scores. The ABRicate genome summary reports were combined 202 
into a single Excel spreadsheet to show the presence and absence of antimicrobial resistance 203 
genes. Visualisation of the comparative antimicrobial resistance gene content was performed 204 
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using the Interactive Tree of Life (iTOL) (v3.5.4) [37] by combing the spreadsheet and core-gene 205 
phylogenetic tree and producing a heat map. 206 
Analysis of the RW109 megaplasmid. The CGView Comparison Tool [38] was used to map the 207 
P. aeruginosa industrial strains, along with clinical strains PA121617 and PA96, to a circular map 208 
of the RW109 plasmid. Prokka generated GeneBank files were used as an input and were 209 
converted into CGView XML files for generation of the genome circular comparison map. For 210 
evolutionary analysis of the plasmid origin, the parB from the RW109 megaplasmid was used to 211 
extract homologous sequences by BLAST from Genbank. A maximum-likehood phylogenetic tree 212 
was generated based on MAFFT alignment of RW109 megaplasmid parB, homologous 213 
sequences identified in 7 industrial and 2 clinical P. aeruginosa strains, and their closest 214 
neighbouring parB genes from characterised Pseudomonas plasmids [39] and other species. 215 
Accession numbers of the sequences analysed were as follows: the RW109 megaplasmid 1 216 
(LT969519.1) and plasmids of the same ancestral family pBM413 (CP016215.1), pSY153-MDR 217 
(KY883660.1), p12969-DIM (KU130294.1), pRBL16 (CP015879.1), pJB37 (KY494864.1), 218 
pTTS12 (NZ_CP009975.1), and pOZ176 (KC543497.1); more distantly related plasmids pTC-219 
F14 (AF325537.2), AMMD p1 (CP000443.1), pAOVO02 (CP000541.1), Rms149 (AJ877225), 220 
pRA2 (U88088.2), pWW0 (AJ344068.1), and pUnnamed1 (NZ_CP029091.1; used as the 221 
phylogenetic root). The megaplasmid and large plasmid copy number was estimated from 222 
mapping of short read sequence data to the complete PacBio P. aeruginosa RW109 reference 223 
sequence using the EDGE bioinformatics platform [40]; the fold coverage of each replicon was 224 
compared to that of the main chromosome to derive the copy number estimate (see 225 
Supplementary Methods).  226 
RESULTS 227 
Industrial P. aeruginosa tolerate preservatives but are diverse in relation to other 228 
phenotypes. A collection of 69 P. aeruginosa isolates (Table S1) was assembled from industrial 229 
products (household  cleaners, laundry liquids, personal care cosmetics, metal working fluids and 230 
timber care products) which were identified as not meeting hygiene standards during quality 231 
control checks of products manufactured between 2001 to 2013; reference stains used in 232 
preservative efficacy testing by industry were also included. Low resolution genotyping (Random 233 
Amplified Polymorphic DNA, RAPD) was used to differentiate sequential isolates and identify 234 
single strains for further analysis (Figure S1). Representative genetically distinct industrial strains 235 
(IND; n=15) were assembled into a testing panel of 40 P. aeruginosa strains from CF (n=10), 236 
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other clinical infections (CLIN; n=9), environmental (ENV; n=5), and unknown (n=1) sources. 237 
Strains from the P. aeruginosa international reference panel (IPARP) [13] were also included 238 
(Table S1). Tolerance towards the following widely used preservatives was evaluated: 239 
isothiazolinones (methylisothiazolinone, MIT; chloromethylisothiazolinone and 240 
methylisothiazolinone blend in the ratio 3:1, CMIT; benzisothiazolinone, BIT), alcohols 241 
(phenoxyethanol, PHE), biguanides (chlorhexidine) and organic acids (benzoic acid, BA) (Figure 242 
1, Table S4 and S5).  243 
P. aeruginosa industrial strains demonstrated high levels of tolerance towards individual 244 
preservatives and individual industrial isolates possessed the maximum preservative MIC values 245 
for all classes (Figure 1, Table S4 and S5). Higher isothiazolinone MIC values (≥0.00375% MIT, 246 
≥ 0.001875% CITMIT and ≥ 0.02% BIT) were predominantly linked with industrial strains (Table 247 
S4). P. aeruginosa strains from industrial sources were found to have significantly higher (P < 248 
0.05) median preservative MICs than strains from CF for the isothiazolinones (Table S4; MIT, 249 
0.0025 compared to 0.001875; CITMIT, 0.0015626 compared to 0.0007815; BIT, 0.01 compared 250 
to 0.005 (Table S4) and PHE (Table S5; 0.4688 compared to 0.2734). Other phenotypes such as 251 
growth rate (Table S6) and motility (Table S7) were variable across the industrial strains.  Only 252 
one strain, the industrial isolate RW200 demonstrated a true swarming phenotype, indicated by 253 
the formation of finger-like projections radiating from the inoculation point (Figure S2, panel A). In 254 
addition, 3 strains of industrial origin sharing the same genotype (RW130, RW131 and RW146; 255 
see below) isolated from a household cleaning product at the same location over several years 256 
(2004-2010), displayed the same unusual swimming motility (Figure S2, panel B).  257 
The ability of the industrial P. aeruginosa strains to form biofilms was also investigated [20]. For 258 
the 16 industrial product isolates there were no associations between biofilm forming capability 259 
(Figure S3) and decreased susceptibility to the preservatives MIT, CITMIT, BIT, PHE, CHX or BA 260 
(Table 1). Biofilm formation across the 16 industrial, 4 CF, 4 clinical, and 2 environmental strains 261 
assessed was variable but showed concordance with published data in terms of high and low 262 
biofilm forming control strains that were included [14]. No association with strain source or 263 
planktonic antimicrobial tolerance was linked to biofilm formation (Figure S3) in correlation with 264 
what has been observed for P. aeruginosa [14] and Burkholderia cepacia complex bacteria [41].  265 
Industrial strains are widely spread across the non-clonal, freely recombining P. 266 
aeruginosa population structure. Multiple genotyping methods of increasing resolution were 267 
employed to examine the placement of industrial strains within the non-clonal recombinant P. 268 
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aeruginosa population structure. A total of 19 representative industrial isolates (Figure S1; 16 269 
industrial product isolates and 3 reference strains used in industry) were subjected to Clondiag 270 
Array-Tube (AT) genotyping [17] to enable comparison to the largest dataset of global strains 271 
currently available. AT-genotypes were obtained for 15 industrial product isolates revealing 11 272 
different strain types (Table S2). To place these strains into a wider context, eBURST [22], was 273 
applied to a total collection of 1464 isolates [17] comprising the industrial genotypes. The 252 274 
genotypes identified within this collection grouped into 1 large and 8 small clonal complexes, and 275 
44 singletons (Figure 2). The eBURST topology was highly similar to that observed by Cramer 276 
and colleagues [42], indicating a diverse spread of strains, with strains from different isolation 277 
sources being spread throughout the P. aeruginosa population (Figure 2). In terms of specific AT-278 
genotypes, 3 of the 11 (27%) of industrial genotypes were novel, with the remaining 8 strain types 279 
found being previously associated with varied habitats such as CF, other clinical settings and the 280 
natural environment, and previously well-documented P. aeruginosa clone types (major clone 281 
types Y, D, B and X).  282 
Whole genome sequencing (WGS) and Multi-locus sequencing typing (MLST) was used to obtain 283 
further information about P. aeruginosa population biology [18, 43]. MLST profiles [24] were 284 
generated for the industrial strains and represented 10 sequence types (STs) composed of known 285 
STs (n=7) and novel STs (n=3) (Table S3). Comparison to the global MLST database showed 286 
that the 7 known STs associated with the industrial strains had been encountered in multiple 287 
environments including CF, clinical infections and the environment (Table S3). ST-2730 was 288 
associated with 3 industrial strains (RW130, 131 and 146) isolated from the same household 289 
cleaner production facility from 2004 to 2010 (Table S3). This persistent P. aeruginosa industrial 290 
strain had a high tolerance towards benzoic acid (Figure 1) and also possessed an atypical 291 
swimming motility (Figure S2). Single industrial P. aeruginosa genotypes were also encountered 292 
in more than one industrial product type, with ST-111 occurring in two different household 293 
cleaning product types (isolates RW192 and RW138), and ST-1342 being encountered within a 294 
personal care cosmetic (isolate RW149) and laundry liquid (isolate RW176) product (Table S3). 295 
High resolution population biology mapping of the P. aeruginosa industrial strains was revealed 296 
by core-gene analysis of an expanded genome collection comprising 103 selected sequences 297 
(Table S1). A total of 4009 core genes were identified within this dataset, aligned and evaluated 298 
phylogenomically (Figure 3). P. aeruginosa split into 2 major groups, with 13 industrial strains 299 
placing in group 1, and 3 locating to group 2 (Figure 3). Three industrial strains possessing the 300 
same MLST sequence type (ST-111), RW138, RW109 and RW192 (Table S3), were located to 301 
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a grouping within group 1, and were all differentiated by core gene analysis (Figure 3). Industrial 302 
strains RW149, RW176, and RW200 also placed within this sub-clade which was comprised only 303 
industrial and clinical strains (n=6 for both; Figure 3). Strains from different sources were widely 304 
dispersed across the core gene population analysis (Figure 3), corroborating the AT-genotyping 305 
(Figure 2). The overall population structure of 2 major groups and a PA7 outlier reflects findings 306 
of studies with both smaller [44](n=55) and larger [45](n=389 strains) datasets.  307 
Industrial P. aeruginosa strains have large multireplicon genomes. To establish a complete 308 
reference genome of an industrial P. aeruginosa strain, single molecule real-time sequencing 309 
(Pacific Biosciences) was applied to strain RW109 which had the largest genome (Table 1; Figure 310 
S4). This strain had originally been isolated from a product contamination incident (personal care 311 
cosmetic product, Europe, 2003; Table S1) and was closely related to 5 other industrial strains 312 
within the same sub-group of group 1 P. aeruginosa (Figure 3). In comparison to the well 313 
characterised clinical reference strains P. aeruginosa PA01 and PA14 [46], industrial strain 314 
RW109 possessed: (i) a substantially larger genome of 7,756,224 bp; (ii) 1402 more predicted 315 
coding sequences than PA14 (the larger of the two well studied reference strains PA14 and 316 
PA01); and (iii) a multireplicon genome (Figure 4) comprising a large chromosomal (7,049,347 317 
bp; GC content 65%) replicon, a megaplasmid (555,265 bp; GC content 58%; plasmid 1) and 318 
large plasmid (151612 bp; GC content 57%; plasmid 2) (Table 1; Figure S4). Other features such 319 
as G+C, rRNA and tRNA content were similar among the 3 strains (Table 1). Overall, the highly 320 
virulent P. aeruginosa PA14 strain genome was 15.7% smaller, and the older PAO1 reference 321 
genome 19.2% smaller, than industrial strain RW109  322 
Comparative genome analysis of the P. aeruginosa industrial product strains revealed multiple 323 
unique traits. Firstly, genes homologous to those encoded by the RW109 megaplasmid were 324 
extensively conserved in other genetically distinct industrial strains (Figure 4, panel A). 325 
Comparative genomic analysis of the RW109 megaplasmid demonstrated that 7 industrial strains 326 
(RW130, RW131, RW146, RW172, RW176, RW184, and RW204) encoded DNA with 327 
considerable synteny across > 250 kbp of this replicon (Figure 4, panel A). Two clinical strains, 328 
PA121617 and PA96 also encoded DNA homologous to RW109 megaplasmid (Figure 4, panel 329 
A). Collectively these P. aeruginosa strains harbouring DNA homologous to the RW109 330 
megaplasmid were widely spread across the species population structure (Figure 3; 7 distinct 331 
MLST sequence types, Table S3). Secondly, evolutionary comparison of the plasmid-specific 332 
partitioning gene, parB [47], showed the RW109 megaplasmid was from a single conserved family 333 
(Figure 4, panel B). The RW109 megaplasmid parB clustered with the parB genes from the same 334 
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7 industrial strains and 2 clinical strains with the homologous gene content (Figure 4, panel A). 335 
The close phylogenetic relationship of the P. aeruginosa RW109 megaplasmid to characterised 336 
plasmids such as pJB37 and pOZ176 [48, 49] indicated it belonged to the Inc-P2 incompatibility 337 
group. By mapping the short read data to the PacBio complete reference sequence, the 338 
megaplasmid copy number was also estimated to be less than 2 (see Supplementary Results), 339 
consistent with the previously reported low copy number associated with Inc-P2 megaplasmids 340 
[48, 49]. Overall, from the genomic (Figure 4A) and phylogenetic (Figure 4B) conservation, the 341 
data suggested that the ancestral backbone of the RW109 megaplasmid had been acquired by 342 
different host strains but was a specific feature of P. aeruginosa industrial strains (Figure 3).  343 
The third trait shared by all industrial P. aeruginosa strains was a larger than average genome 344 
size for the species (Figure 5). The industrial strain genomes were on average 5.7% (>380,000 345 
bp) larger than P. aeruginosa strains from other sources (Figure 5), despite their genetic 346 
heterogeneity at the strain level (Figure 3). Examination of the genome size distribution for all 103 347 
P. aeruginosa revealed a mean size of 6,706,516 bp. Five P. aeruginosa industrial strains, 348 
RW109, RW146, RW130, RW131, RW172, were outliers possessing the largest genomes in the 349 
dataset, with only one other strain, the clinically derived Carb01-63 encoding a similar overall 350 
DNA content (Figure 5, panel A). The distribution of genome sizes in relation to strain source 351 
(Figure 5, panel B and C) demonstrated that overall, P. aeruginosa recovered from industrial 352 
settings possessed significantly larger genomes with a mean size of 7,040,410 bp, compared to 353 
clinical strains (mean, 6,660,367 bp; p = 0.0012) and environmental strains (mean 6,516,837 bp; 354 
p = 0.0002; two-sample t test assuming unequal variance). In the case of the industrial P. 355 
aeruginosa strains RW109, RW130, RW131, RW146, RW172, RW176, RW184, and RW204, 356 
presence of the conserved megaplasmid was likely a contributing factor for this increased overall 357 
genome size (Figure 4 panel A and B). 358 
Industrial P. aeruginosa strains have equivalent overall antimicrobial resistance gene 359 
content. Antimicrobial resistance (AMR) genes were predicted from 103 P. aeruginosa genomes 360 
using the Comprehensive Antibiotic Resistance Database (CARD) [50]. Visualization of the 361 
predicted AMR genes demonstrated that industrial strains encoded a similar range of antibiotic 362 
resistance genes to P. aeruginosa strains from other environments (Figure 6). The mean number 363 
of CARD resistance genes was determined as 43 for CF and clinical strains, 41 for environmental 364 
strains and 41 for industrial strains. All 103 genome sequences had the polymyxin resistance 365 
genes pmrB and arnA and the aminoglycoside resistance gene OXA-50. Within the industrial 366 
genome sequences, RW109 and RW192 were the only two with the beta-lactamase PDC-1 gene; 367 
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this gene was also found within seven clinical strains (Figure 4; ATCC-15692, H27930, H5708, 368 
PA121617, PAO1, VA-134, and W16407). CARD did not identify any antimicrobial resistance 369 
genes associated with the quinolone, carbapenem, trimethoprim, macrolide and tetracycline efflux 370 
resistance functional groups. The majority of the genes which encode the Mex-type efflux pump 371 
systems were found in all P. aeruginosa industrial strains; exceptions were oprA (absent from all 372 
industrial strain genomes) and the mexY gene which was specifically absent in RW109.  373 
Pan-genome and presence/absence analysis was performed with the 103 P. aeruginosa genome 374 
dataset to determine genes unique to RW109. A total of 329 genes were found to be specific to 375 
the industrial strain, with 202 encoded on the main chromosome, 105 on megaplasmid 1 and 22 376 
on plasmid 2. Over half (51%) of the RW109 unique genes were identified as poorly characterised 377 
by COG annotation assessment. No CARD predicted antimicrobial resistance genes were found 378 
within the unique subset of RW109 genes. However, 5 genes associated with a BpeEF-OprC type 379 
efflux pump [51] identified by KEGG analysis (module M00698, Module Completeness Ratio 380 
[MCR] of 100% and Q-Value of 0), were encoded by the RW109 megaplasmid (genes 381 
RW109_00010 through RW109_00014). Industrial strains RW130, RW146, RW172, RW176 and 382 
RW184, all of which likely possessed a megaplasmid from the same family of as that of RW109 383 
(Figure 4), also encoded the same KEGG-predicted efflux pump genes (MCR of 100% and a Q-384 
value of 0). Genes homologous to the BpeEF-OprC type efflux pump were not identified in any of 385 
the remaining 97 P. aeruginosa genome sequences. The industrial strains possessing the BpeEF-386 
OprC efflux pump genes were genetically distinct and spread across both major groups of the P. 387 
aeruginosa population structure (Figure 3). 388 
KEGG functional module pathway analysis was carried out on four isolates with the highest MICs 389 
and four with the lowest MICs for the preservatives BIT, MIT, CITMIT, PHE and CHX (see Figure 390 
1; Table S4 and S5). Overall, there were minimal differences in the numbers of complete modules 391 
assigned to the categories between the isolates with high and low preservative MICs (Figure S5 392 
and S6). Significant differences were associated with a limited number of functional module 393 
pathways including drug resistance, central carbohydrate metabolism, bacterial secretion 394 
systems and two component regulatory system categories (see Supplementary Results; Figure 395 
S5 and S6).  396 
DISCUSSION 397 
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Researchers commonly portray P. aeruginosa as ubiquitous, linking this descriptor to its diverse 398 
phenotypic and genotypic traits, and multiple isolation sources. As an opportunistic pathogen, P. 399 
aeruginosa has been the subject of extensive investigation, but outside of clinical settings it has 400 
received much less attention despite its problematic nature when encountered. With the number 401 
of consumer products including preservatives increasing [52], and the production volume of 402 
biocidal compounds several orders of magnitude higher than those of antibiotics [53], industrial 403 
manufacturing environments represent a key niche for stress tolerant organisms such as P. 404 
aeruginosa. However, in contrast to infection where P. aeruginosa isolates are frequently 405 
genotyped and archived to enable global epidemiological analysis, no systematic collections of 406 
P. aeruginosa isolates from industrial contamination have been assembled. By establishing a 407 
unique collection of P. aeruginosa isolates from industrial sources spanning a decade, different 408 
global locations and multiple product types, we have shown that they possess multireplicon 409 
genomes encoding 300 kb of extra DNA compared to strains from other sources.  410 
Preserved industrial products represent an environment where antimicrobial compounds may 411 
exist within a concentration gradient ranging from lethal to sub-lethal concentrations [52], and 412 
such conditions place huge selective pressure on potential contaminating microorganisms such 413 
as P. aeruginosa. Understanding the fitness advantage that P. aeruginosa gains from retaining 414 
genomic and megaplasmid content for survival within industrial environments is vital to develop 415 
improved preservation strategies and formulations. The International P. aeruginosa Consortium 416 
is sequencing over 1000 genomes to study genome evolution, antibiotic resistance and virulence 417 
genes [45]. Initial findings from this project examining the core genomic content of 389 strains 418 
identified 3 major phylogenetic groups: 1, which contained well studied reference strains such as 419 
PAO1 [54] and LESB58  [55]; 2, where the virulent reference strain PA14 [56] resided; and 3, 420 
containing isolate PA7 [57] as an outlier. Our core gene analysis of a representative set of 103 P. 421 
aeruginosa genomes mirrored this analysis, and moreover has shed light on the widespread 422 
dispersal of industrial strains within both major phylogenetic groups (Figure 3). 423 
The consensus population structure of P. aeruginosa is non-clonal epidemic, composed of freely-424 
recombining isolates without habitat selection, but with evidence of globally distributed major 425 
clone types such as Clone C and PA14 [3]. Confounding this model are potential niche specialists 426 
in clinical and environmental settings [3, 58-60]. To date, the largest P. aeruginosa population 427 
structure analysis has used AT-genotyping to examine 2192 isolates from 1448 independent 428 
habitats and included 8 isolates from oil contaminated environments, but did not evaluate 429 
representative strains from contaminated  industrial products [17]. We found that these industrial 430 
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P. aeruginosa strains were diverse and a mixture of novel and previously encountered AT-431 
genotypes (Figure 2). A recent small-scale study of animal infection as an under-reported niche 432 
of P. aeruginosa, found the same diversity of genotypes within carbapenem resistant strains [61]. 433 
The industrial AT-genotypes were spread widely throughout the topology of the eBURST analysis 434 
(Figure 2) corroborating the non-clonal epidemic hypothesis of P. aeruginosa population structure 435 
[42]. Furthermore, investigating the antimicrobial resistance gene content did not provide an 436 
obvious genetic link to the increased preservative tolerance of the industrial strains (Figure 1), as 437 
strains of different origin shared similar numbers of core genome antimicrobial resistance 438 
determinants (Figure 6). Sharing of resistance capabilities and a lack of clonal specialisation in 439 
relation to antimicrobial phenotypes has been previously reported for P. aeruginosa strains from 440 
different environments [62]. 441 
Despite this population mixing and multiple ubiquitous traits being shared among P. aeruginosa 442 
strains, our genomic analysis of industrial strains demonstrated specialisation towards 443 
possession of greater genomic capacity and multiple replicon genomes. It is interesting that 444 
Burkholderia, well known for their multi-replicon genome structure, are also highly stress tolerant 445 
and intrinsically antimicrobial resistant [63]. A key feature of the reference industrial genome for 446 
P. aeruginosa strain RW109 defined herein was the presence of a 555 kbp megaplasmid (Figure 447 
4). Megaplasmids are well known to encode a wide range of accessory fitness traits that contribute 448 
specialist ecological lifestyles [47]. The RW109 megaplasmid origin was conserved within seven 449 
other industrial strains and its gene content homologous to megaplasmids within Pseudomonas 450 
species recovered from a wide variety of stressful environments (Figure 4, panel A and B). These 451 
Pseudomonas megaplasmids (all >370 kbp) have each been characterised individually for their 452 
fitness-contributing roles in: clinical multidrug resistance for pSY153-MDR, pBM413, p12969-453 
DIM, and pOZ176 ([64], and pJB37 [48]; mediating biodegradation processes such as oestrogen 454 
and aromatic hydrocarbon breakdown in wastewater treatment (pRBL16) [65]; and, solvent 455 
tolerance and the production of aromatic hydrocarbons (pTTS12) [66]. The Pseudomonas putida 456 
megaplasmid, pTTS12 (583 kbp) is the largest characterised for the genus to date [66], and the 457 
RW109 megaplasmid (555 kbp)  uniquely identified in this study is the largest associated with a 458 
strain of P. aeruginosa. Recent analysis of P. aeruginosa isolates recovered from patients at a 459 
hospital in Thailand also show that the same closely related family of megaplasmids encode 460 
multidrug resistance elements, are highly recombinogenic and mediate extensive gene transfer, 461 
and have likely been carrying resistance genes dating back to the late 1970s [67]. 462 
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Specific characterisation of this unique megaplasmid family in relation to the wider fitness they 463 
bring to Pseudomonas, as well as their role in preservative tolerance within industrial isolates is 464 
worthy of further understanding. Our initial analysis has demonstrated no clear association of 465 
megaplasmid to P. aeruginosa phenotypes such as growth rate (Table S6), motility (Table S7) or 466 
biofilm formation (Figure S3), but overall the industrial strains harbouring the plasmid showed 467 
elevated levels of preservative tolerance (Figure 1). The KEGG functional module content was 468 
also broadly the same for the comparison of the limited numbers of well characterised 469 
preservative tolerant and sensitive P. aeruginosa strains we were able to compare (Figure S5 and 470 
S6). It was interesting that the bacterial secretion category was enriched in isothiazolinone 471 
tolerant P. aeruginosa strains (Figure S5), and that the BpeEF-OprC type efflux pump was an 472 
underpinning pathway in this functional content difference (Supplementary Results). Systematic 473 
comparison of large numbers of P. aeruginosa strains and functional analysis of the implicated 474 
gene pathways will be required to fully validate these initial correlations. While projects such as 475 
1000 genomes study [45] are delivering extensive sequence information, more data for poorly 476 
studied phenotypes such as preservative tolerance is required to perform high resolution 477 
comparative analysis of P. aeruginosa. 478 
Conclusions. P. aeruginosa is rightly described as an opportunistic pathogen, but the data 479 
presented herein points towards the fact that it is actually a highly opportunistic organism, 480 
possessing genomic flexibility that enables it to take advantage of new niches wherever it can find 481 
them. The current study has uniquely characterised a collection of P. aeruginosa strains of 482 
industrial origin, impacting global product manufacture and increasing our understanding of this 483 
important bacterial species. P. aeruginosa is a common contaminant in xenobiotic settings and 484 
we identified problematic strains with high preservative tolerance that were capable of causing 485 
recurrent industrial incidents. These findings suggested that industrial strains possessed elevated 486 
fitness levels and present a case for strain typing and tracking within manufacturing environments 487 
as part of quality control. Further investigation into preservative tolerance will inform preservative 488 
system development and evaluation, but also requires appropriate model strains. The prototypic 489 
strains PAO1 and PA14 [46] had significantly smaller genomes and lower preservative tolerances 490 
than industrial strains. We focussed our attention on P. aeruginosa RW109 and defined a 491 
complete reference genome for this industrial strain, discovering it possessed one of the largest 492 
genomes and a megaplasmid associated with the species. Whilst there may not be specialised 493 
clones within industry, understanding the potential fitness advantage of the extra genomic content 494 
and megaplasmids shared by P. aeruginosa industrial strains is a key future challenge. 495 
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FIGURE LEGENDS 682 
Figure 1. P. aeruginosa demonstrates high tolerance of preservatives commonly used in 683 
industry.   The minimum inhibitory concentrations (MICs) of preservatives were determined for 684 
the sub-panel of 40 P. aeruginosa strains. MIC data was visualised using boxplots and the 685 
median, upper quartile, lower quartile, maximum and minimum values are displayed. Data points 686 
are shown by open circles and  outliers (minimum and maximum) are labelled with the strain 687 
name(s) possessing that MIC. Panels are labelled as follows: MIT, methylisothiazolinone; CITMIT, 688 
chloromethylisothiazolinone and methylisothiazolinone blend in the ratio 3:1; BIT, 689 
benzisothiazolinone; PHE, phenoxyethanol; CHX, chlorhexidine; and BA, benzoic acid. 690 
Figure 2. Industrial P. aeruginosa strains are widely distributed across the AT-genotype 691 
inferred population. The clonal complex structures of 1464 strains is shown and includes strains 692 
from CF, other human infections, and environmental sources, as well as 1446 strains analysed 693 
by Wiehlmann et al. (2015).  The industrial and efficacy testing P. aeruginosa strains (Table S2) 694 
were analysed and placed within the inferred population as follows.  Clonal complexes were 695 
calculated from the 16-marker AT genotype of the core genome by the eBURST algorithm; the 696 
major P. aeruginosa clonal complex and 8 additional groups have been highlighted with a blue 697 
background. AT-genotypes are indicated by the black, blue and yellow circles, with the diameter 698 
of the circle being proportional to the number of isolates with this genotype. Founding AT-699 
genotypes are shown in blue, subfounders in yellow and prevalent clones are marked with light 700 
blue letters next to their corresponding AT-genotype.  The industry-associated P. aeruginosa 701 
strains are marked with closed (previously reported AT-genotypes) or broken (novel AT-702 
genotypes) red circles, and their AT-genotype indicated (Table S2). The position of the industrial 703 
strain RW109 is highlighted by the blue arrow and the orange box enclosed AT-genotype. 704 
Figure 3. Widespread placement of industrial isolates within the core-gene based 705 
population structure of P. aeruginosa. A maximum-likehood phylogenetic tree was generated 706 
based on the 4009 core genes identified within the 103 P. aeruginosa genomes. Strain names 707 
are colour coded to indicate their source as: clinical (red, n=66), environmental (green, n=19) or 708 
industrial (blue, n=16); strain PA1RG is classified as both clinical and environmental so is coloured 709 
red and green, and ATCC-13388 is coloured in grey as it has an unknown source of isolation. 710 
Bootstrap values (with 1 being 100%) and genetic distance (the number of base substitutions per 711 
site) are indicated on the nodes and scale bar, respectively. The tree was rooted with the PA7 712 
genome sequence as the most divergent P. aeruginosa strain. The two major P. aeruginosa 713 
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groups are labelled (1 and 2), and the highlighted clade (purple square) containing the industrial 714 
strain, RW109, with a complete reference genome, are shown. Industrial strains uniquely 715 
encoding the BpeEF-OprC efflux pump (blue arrows; E) and megaplasmid parB gene (black 716 
arrows; P) are indicated.  717 
Figure 4. Homology of the RW109 megaplasmid and its conservation among extreme 718 
stress tolerant Pseudomonas strains. Panel A. The CGView Comparison Tool  [38] was used 719 
to map the P. aeruginosa industrial strain sequences, along with clinical strains PA121617 and 720 
PA96, to a circular map of the RW109 megaplasmid. Prokka generated GeneBank files were 721 
used as an input and were converted into CGView XML files for generation of the genome circular 722 
comparison map. The colour coded key shows regions of each strain with homology to the 723 
megaplasmid, with their source indicated by the brackets. The blue arrows indicate the 724 
approximate location of the conserved BpeEF-OprC efflux pump present in industrial strains. 725 
Panel B shows a maximum-likelihood phylogenetic tree of RW019 megaplasmid parB gene 726 
(green text) aligned against homologous sequences from the P. aeruginosa industrial strains (blue 727 
text) and other related Pseudomonas plasmids. Industrial strains uniquely encoding components 728 
of the BpeEF-OprC efflux pump are indicated by the blue arrows. Bootstrap values are indicated 729 
at the node (diamonds; white nodes ≥75% and black nodes ≤75%) and the genetic distance (the 730 
number of base substitutions per site) indicated on the branches and by the scale bar. The tree 731 
was rooted with parB gene from an unnamed plasmid in P. aeruginosa strain AR441.  732 
Figure 5. P. aeruginosa strains from industrial product contamination possess 733 
considerably larger genomes that those from other sources. The distribution of the genome 734 
sizes for the 103 P. aeruginosa sequences were visualised using boxplots which display the 735 
median (black horizontal line), upper quartile, lower quartile, maximum and minimum values. The 736 
mean values are also represented with a cross. Outliers are shown as open circles outside of the 737 
boxplots with the strain names and genome sizes indicated. A boxplot to represent the genome 738 
size distribution of the 103 sequences combined are shown in A. The sequences were also 739 
divided into three boxplots (B) to indicate the genome sizes of the clinical strains (red, n = 66), 740 
environmental strains (green, n=19) and industrial (blue, n = 16). The values for the median and 741 
mean genome sizes (bp) for the clinical, environmental and industrial strains are shown in panel 742 
C. 743 
Figure 6. Predicted antimicrobial resistance gene content of the 103 P. aeruginiosa 744 
genomes. Using the core-gene phylogenomic analysis to place each P. aeruginosa genome in 745 
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evolutionary context, a presence/absence heat map was used to visualise the CARD-predicted 746 
antimicrobial resistance genes content. P. aeruginosa genome sequences of clinical (red), 747 
environmental (green) and industrial (blue) strains are indicated. The CARD antimicrobial genes 748 
were grouped via their predicted resistance functions (top of the heat map), with light blue showing 749 
absence and dark blue indicating the presence of the antimicrobial resistance gene. The clade 750 
containing the industrial reference strain, RW109, for which a complete genome was determined 751 
is highlighted (purple box).   752 
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Table 1. Comparative genome features of the industrial P. aeruginosa strain 
RW109 and reference strains PA14 and PAO1 
Genome Features Industrial strain 
RW109 
Reference strains 
PA14 PAO1 
Genome size (bp) 7756224 6537648 6264404 
Replicons 3 1 1 
DNA G+C content (%) 65.11 66.29 66.56 
Coding sequences 
(CDS) 
7303 5901 5671 
No. hypothetical 
proteins 
2199 2026 1858 
rRNA genes 12 12 12 
tRNA genes 76 69 73 
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